Join Vaccine World Asia Congress 2021Download Brochure
Showcase Your Solutions
Thought Leadership, Product Showcase, Lead Generation, Branding and Other Opportunities Available!Download Sponsorship Prospectus
Explore Learning & Networking Opportunities On Our Virtual Event Platform!Download Brochure
Due to increasing healthcare expenditure, advancing vaccine technology, and rising demand for preventives vaccines, especially new COVID-19 vaccines, the Asia-Pacific preventive vaccines market will rise by 12.89% annually with a total addressable market cap of $97.2 billion between 2020 and 2026.
Coronavirus infection has recently infected millions of people all over the world. In certain areas, community transmission has resulted in an increase in global casualties. At present, Big pharma and biopharma are concentrating their efforts on COVID-19 vaccine research and development. The COVID-19 pandemic situation has generated unprecedented demand, and companies are heavily investing in R&D activities, with government support as well as technological advancement to shorten the clinical trial duration and increase production efficiency. The market's growth prospects will be bolstered by the expansion of vaccine manufacturing facilities to meet the rising demand.
Vaccine World Asia Congress 2021 will be the only vaccine-focused platform in Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the Big Pharmas, International Biopharma, Asian Biopharma, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers, and Technocrats.
With this edition of Vaccine World Asia, we have co-located with Asia-Pacific Vaccine Excellence Awards. If Asia’s vaccine business matters to you, then Vaccine World Asia Congress 2021 is the place to be!
Vaccine World Asia Congress will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the BIG Pharmas, International Biopharma’s, Asian Biopharmas, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccines business matters to you, then Vaccine World Asia 2021 is the place to be!
Jerome H. Kim International Vaccine Institute
Zhong Kai Shi Yisheng Biopharma
Han S Kierstead AIVITA Biomedical
Raches Ella Bharat Biotech
Mark Newman GeoVax
Samir Desai Cadila Healthcare Limited (Zydus Cadila)
Randall Hyer Moderna
Joseph Payne Arcturus Therapeutics
Alexandre, Le Vert Osivax
Ingrid Kromann CEPI
Rong Xu Clover Biopharmaceuticals
Kevin Wang, Ph.D CC-Pharming Ltd.
Kiat Ruxrungtham, MD Department of Medicine Chulalongkorn University; and Scientific Chair of the Chula Vaccine Research Center (ChulaVRC)
Rajinder Kumar Suri DCVMN
Vasan K Sambandamurthy India Alliance
Dr. Farshad Guirakhoo COVAXX and VAXXINITY
Elena Smith Sanofi Pasteur
Etleva Kadilli UNICEF
Yujiao Chen Beijing CC-Pharming
Dr. Gaurab Sircar Visva Bharati University, Santiniketan,
Sanjeev Kumar, Ph.D International Centre for Genetic Engineering and Biotechnology (ICGEB),
Ajoy Chakrabarti Bill & Melinda Gates Foundation
Matthew Downham CEPI
Nguyen Tuyet Nga PATH
Frank Malinoski Eveliqure Biotechnologies
Daniel R. Vlock Alopexx
Dave E. Anderson VBI Vaccines
Ada Wong Sanofi
Per Fischer Minervax
Kirill Dmitriev Russian Direct Investment Fund
S S Vasan CSIRO
Luis Rios-Nogales ILiAD Biotechnologies
Technology Showcase Sponsor
Vaccine World Asia Congress 2021 will provide you with the opportunity to educate the market about your offerings and position yourselves as leaders in your field alongside key industry figures! This is an EXCEPTIONAL opportunity to position your brand and business before the Asia’s top vaccine executives. Make sure you get access to the region’s hottest life science sub-sector.